{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T02:19:17Z","timestamp":1782094757598,"version":"3.54.5"},"reference-count":120,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ccl.2021.05.001","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T22:14:25Z","timestamp":1625782465000},"page":"455-469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cardiorenal Syndrome"],"prefix":"10.1016","volume":"39","author":[{"given":"Parta","family":"Hatamizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ccl.2021.05.001_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneph.2012.279","article-title":"Cardiorenal syndrome: pathophysiology and potential targets for clinical management","volume":"9","author":"Hatamizadeh","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"2761","key":"10.1016\/j.ccl.2021.05.001_bib2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/bmj.2.2761.1417","article-title":"A\u00a0clinical lecture on paroxysmal dyspnoea in cardiorenal patients: with special reference to \u201ccardiac\u201d and \u201curaemic\u201d asthma: delivered at University College Hospital, London, November 12th, 1913","volume":"2","author":"Lewis","year":"1913","journal-title":"Br Med J"},{"key":"10.1016\/j.ccl.2021.05.001_bib3","series-title":"Cardiorenal connections in heart failure and cardiovascular disease","year":"2004"},{"issue":"19","key":"10.1016\/j.ccl.2021.05.001_bib4","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2021.05.001_bib5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative","volume":"31","author":"Ronco","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2021.05.001_bib6","series-title":"Chronic kidney disease in the United States, 2021","year":"2021"},{"issue":"10225","key":"10.1016\/j.ccl.2021.05.001_bib7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ccl.2021.05.001_bib8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2215\/CJN.04961107","article-title":"Epidemiology of acute kidney injury","volume":"3","author":"Cerd\u00e1","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4 Suppl","key":"10.1016\/j.ccl.2021.05.001_bib9","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1097\/CCM.0b013e318168c590","article-title":"Epidemiology of acute kidney injury: how big is the problem?","volume":"36","author":"Hoste","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccl.2021.05.001_bib10","series-title":"Heart disease resources for health professionals, heart failure","year":"2020"},{"issue":"10159","key":"10.1016\/j.ccl.2021.05.001_bib11","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ccl.2021.05.001_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.ccl.2021.05.001_bib13","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/eurheartj\/ehi859","article-title":"Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH)","volume":"27","author":"Cowie","year":"2006","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ccl.2021.05.001_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacc.2003.07.031","article-title":"Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure","volume":"43","author":"Forman","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2021.05.001_bib15","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","article-title":"High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database","volume":"13","author":"Heywood","year":"2007","journal-title":"J\u00a0Card Fail"},{"issue":"9","key":"10.1016\/j.ccl.2021.05.001_bib16","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0002-9149(00)00705-0","article-title":"Correlates and impact on outcomes of worsening renal function in patients\u00a0> or\u00a0=65 years of age with heart failure","volume":"85","author":"Krumholz","year":"2000","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.ccl.2021.05.001_bib17","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","article-title":"Renal impairment and outcomes in heart failure: systematic review and meta-analysis","volume":"47","author":"Smith","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.ccl.2021.05.001_bib18","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccl.2021.05.001_bib19","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1172\/JCI101867","article-title":"The effect of increased intra-abdominal pressure on renal function in man","volume":"26","author":"Bradley","year":"1947","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.ccl.2021.05.001_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1113\/jphysiol.1931.sp002761","article-title":"The influence of venous pressure on the isolated mammalian kidney","volume":"72","author":"Winton","year":"1931","journal-title":"J\u00a0Physiol"},{"issue":"7","key":"10.1016\/j.ccl.2021.05.001_bib21","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2008.08.080","article-title":"Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease","volume":"53","author":"Damman","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ccl.2021.05.001_bib22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2021.05.001_bib23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2007.09.043","article-title":"Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function?","volume":"51","author":"Mullens","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ccl.2021.05.001_bib24","first-page":"528","article-title":"Progression of preclinical diastolic dysfunction to the development of symptoms","volume":"96","author":"Correa de Sa","year":"2010","journal-title":"Heart (British Cardiac Society)"},{"issue":"5","key":"10.1016\/j.ccl.2021.05.001_bib25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccl.2021.05.001_bib26","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.kint.2019.02.022","article-title":"Heart failure in chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"95","author":"House","year":"2019","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.ccl.2021.05.001_bib27","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.cardfail.2008.07.236","article-title":"Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure","volume":"14","author":"Maeder","year":"2008","journal-title":"J\u00a0Card Fail"},{"issue":"10","key":"10.1016\/j.ccl.2021.05.001_bib28","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCRESAHA.111.245092","article-title":"Treatment of chronic heart failure with \u03b2-adrenergic receptor antagonists: a convergence of receptor pharmacology and clinical cardiology","volume":"109","author":"Bristow","year":"2011","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.ccl.2021.05.001_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM198207223070401","article-title":"Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts","volume":"307","author":"Bristow","year":"1982","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccl.2021.05.001_bib30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.RES.59.3.297","article-title":"Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure","volume":"59","author":"Bristow","year":"1986","journal-title":"Circ Res"},{"issue":"9756","key":"10.1016\/j.ccl.2021.05.001_bib31","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial","volume":"376","author":"Esler","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ccl.2021.05.001_bib32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/HYPERTENSIONAHA.112.193870","article-title":"Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension","volume":"60","author":"Mahfoud","year":"2012","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.ccl.2021.05.001_bib33","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/ndt\/gfx088","article-title":"Renal safety of catheter-based renal denervation: systematic review and meta-analysis","volume":"32","author":"Sanders","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"99","key":"10.1016\/j.ccl.2021.05.001_bib34","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1111\/j.1523-1755.2005.09911.x","article-title":"The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease","author":"Remuzzi","year":"2005","journal-title":"Kidney Int Suppl"},{"issue":"82","key":"10.1016\/j.ccl.2021.05.001_bib35","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1046\/j.1523-1755.62.s82.4.x","article-title":"Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney","author":"Ruiz-Ortega","year":"2002","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"10.1016\/j.ccl.2021.05.001_bib36","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0735-1097(83)80040-0","article-title":"Increased plasma arginine vasopressin levels in patients with congestive heart failure","volume":"1","author":"Goldsmith","year":"1983","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2021.05.001_bib37","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/01.CIR.95.6.1363","article-title":"Plasma adenosine levels increase in patients with chronic heart failure","volume":"95","author":"Funaya","year":"1997","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccl.2021.05.001_bib38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejheart.2008.01.010","article-title":"Adenosine and kidney function: potential implications in patients with heart failure","volume":"10","author":"Vallon","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.ccl.2021.05.001_bib39","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1152\/physrev.00031.2005","article-title":"Adenosine and kidney function","volume":"86","author":"Vallon","year":"2006","journal-title":"Physiol Rev"},{"issue":"12","key":"10.1016\/j.ccl.2021.05.001_bib40","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2215\/CJN.03500412","article-title":"Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC","volume":"7","author":"Gupta","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ccl.2021.05.001_bib41","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0735-1097(96)00268-9","article-title":"Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension","volume":"28","author":"Testa","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2021.05.001_bib42","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1681\/ASN.2015030261","article-title":"Inflammation in AKI: current understanding, key questions, and knowledge gaps","volume":"27","author":"Rabb","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1\u20133","key":"10.1016\/j.ccl.2021.05.001_bib43","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000368940","article-title":"Update on inflammation in chronic kidney disease","volume":"39","author":"Akchurin","year":"2015","journal-title":"Blood Purif"},{"issue":"6","key":"10.1016\/j.ccl.2021.05.001_bib44","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrneph.2017.52","article-title":"The systemic nature of CKD","volume":"13","author":"Zoccali","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1016\/j.ccl.2021.05.001_bib45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","article-title":"Reappraising the role of inflammation in heart failure","volume":"17","author":"Adamo","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"25","key":"10.1016\/j.ccl.2021.05.001_bib46","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"issue":"26","key":"10.1016\/j.ccl.2021.05.001_bib47","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"de Zeeuw","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.ccl.2021.05.001_bib48","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2008.01.068","article-title":"Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study","volume":"51","author":"Hare","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.ccl.2021.05.001_bib49","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.ccl.2021.05.001_bib50","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"},{"issue":"9645","key":"10.1016\/j.ccl.2021.05.001_bib51","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"issue":"9608","key":"10.1016\/j.ccl.2021.05.001_bib52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(08)60134-8","article-title":"Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial","volume":"371","author":"Torre-Amione","year":"2008","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ccl.2021.05.001_bib53","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure","volume":"139","author":"Everett","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccl.2021.05.001_bib54","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/0735-1097(94)90385-9","article-title":"Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators","volume":"23","author":"Benedict","year":"1994","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2021.05.001_bib55","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.CIR.63.3.645","article-title":"Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure","volume":"63","author":"Dzau","year":"1981","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccl.2021.05.001_bib56","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-101-3-370","article-title":"The neurohumoral axis in congestive heart failure","volume":"101","author":"Francis","year":"1984","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ccl.2021.05.001_bib57","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0735-1097(00)01121-9","article-title":"Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy","volume":"37","author":"Ohtsuka","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ccl.2021.05.001_bib58","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0735-1097(99)00495-7","article-title":"Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure","volume":"34","author":"Gullestad","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ccl.2021.05.001_bib59","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/S0735-1097(03)00471-6","article-title":"Increased myocardial NADPH oxidase activity in human heart failure","volume":"41","author":"Heymes","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2021.05.001_bib60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1523-1755.2003.00702.x","article-title":"Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency","volume":"63","author":"Vaziri","year":"2003","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.ccl.2021.05.001_bib61","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis","volume":"9","author":"Brown","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1016\/j.ccl.2021.05.001_bib62","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","article-title":"Continuum of renin-independent aldosteronism in normotension","volume":"69","author":"Baudrand","year":"2017","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ccl.2021.05.001_bib63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ccl.2021.05.001_bib64","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2215\/CJN.04750908","article-title":"Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis","volume":"4","author":"Navaneethan","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.ccl.2021.05.001_bib65","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccl.2021.05.001_bib66","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the randomized aldactone evaluation study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.ccl.2021.05.001_bib67","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ccl.2021.05.001_bib68","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.trsl.2014.04.010","article-title":"Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management","volume":"164","author":"Alpert","year":"2014","journal-title":"Transl Res"},{"issue":"1","key":"10.1016\/j.ccl.2021.05.001_bib69","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.arrt.2003.10.007","article-title":"Is obesity a major cause of chronic kidney disease?","volume":"11","author":"Hall","year":"2004","journal-title":"Adv Ren Replace Ther"},{"issue":"4","key":"10.1016\/j.ccl.2021.05.001_bib70","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.hfc.2012.06.005","article-title":"Insulin resistance and heart failure: molecular mechanisms","volume":"8","author":"Aroor","year":"2012","journal-title":"Heart Fail Clin"},{"issue":"6","key":"10.1016\/j.ccl.2021.05.001_bib71","doi-asserted-by":"crossref","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","article-title":"Insulin resistance in chronic kidney disease: a systematic review","volume":"311","author":"Spoto","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4 Suppl 2","key":"10.1016\/j.ccl.2021.05.001_bib72","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1681\/ASN.2005121320","article-title":"Lipids and renal disease","volume":"17","author":"Trevisan","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"23","key":"10.1016\/j.ccl.2021.05.001_bib73","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/CIRCULATIONAHA.109.830984","article-title":"Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study","volume":"120","author":"Velagaleti","year":"2009","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ccl.2021.05.001_bib74","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1210\/jc.2008-0784","article-title":"Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography","volume":"93","author":"Pilz","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ccl.2021.05.001_bib75","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0735-1097(02)02624-4","article-title":"Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?","volume":"41","author":"Zittermann","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ccl.2021.05.001_bib76","doi-asserted-by":"crossref","first-page":"R969","DOI":"10.1152\/ajpregu.00322.2013","article-title":"Vitamin D and the heart","volume":"305","author":"Gardner","year":"2013","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"Suppl 4","key":"10.1016\/j.ccl.2021.05.001_bib77","doi-asserted-by":"crossref","first-page":"iv17","DOI":"10.1093\/ndt\/gfs534","article-title":"Vitamin D receptor activation and cardiovascular disease","volume":"27","author":"Gonzalez-Parra","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"17","key":"10.1016\/j.ccl.2021.05.001_bib78","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/CIRCULATIONAHA.111.032680","article-title":"Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy","volume":"124","author":"Chen","year":"2011","journal-title":"Circulation"},{"issue":"3\u20135","key":"10.1016\/j.ccl.2021.05.001_bib79","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jsbmb.2006.12.098","article-title":"Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse","volume":"103","author":"Simpson","year":"2007","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"5","key":"10.1016\/j.ccl.2021.05.001_bib80","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.0954-6820.1987.tb10959.x","article-title":"Blood pressure is lowered by vitamin D (alphacalcidol) during long-term treatment of patients with intermittent hypercalcaemia. A double-blind, placebo-controlled study","volume":"222","author":"Lind","year":"1987","journal-title":"Acta Med Scand"},{"issue":"5","key":"10.1016\/j.ccl.2021.05.001_bib81","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/HYPERTENSIONAHA.109.140160","article-title":"Vitamin D and hypertension: current evidence and future directions","volume":"56","author":"Vaidya","year":"2010","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.ccl.2021.05.001_bib82","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1210\/me.2011-1329","article-title":"Vitamin D receptor signaling inhibits atherosclerosis in mice","volume":"26","author":"Szeto","year":"2012","journal-title":"Mol Endocrinol"},{"issue":"12","key":"10.1016\/j.ccl.2021.05.001_bib83","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1161\/ATVBAHA.110.215459","article-title":"Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions","volume":"30","author":"Takeda","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.ccl.2021.05.001_bib84","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/HYPERTENSIONAHA.109.148619","article-title":"Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans","volume":"55","author":"Forman","year":"2010","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ccl.2021.05.001_bib85","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0272-6386(99)70260-X","article-title":"Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism","volume":"33","author":"Park","year":"1999","journal-title":"Am J kidney Dis"},{"key":"10.1016\/j.ccl.2021.05.001_bib86","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2350-2-2","article-title":"The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians","volume":"2","author":"Chiu","year":"2001","journal-title":"BMC Med Genet"},{"issue":"4","key":"10.1016\/j.ccl.2021.05.001_bib87","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1210\/endo-113-4-1511","article-title":"Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion","volume":"113","author":"Chertow","year":"1983","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.ccl.2021.05.001_bib88","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.HYP.35.5.1154","article-title":"Relation between low calcium intake, parathyroid hormone, and blood pressure","volume":"35","author":"Jorde","year":"2000","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.ccl.2021.05.001_bib89","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1097\/01.hjh.0000179764.40701.36","article-title":"Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men","volume":"23","author":"Jorde","year":"2005","journal-title":"J\u00a0Hypertens"},{"issue":"11","key":"10.1016\/j.ccl.2021.05.001_bib90","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurjhf\/hfq134","article-title":"Plasma parathyroid hormone and risk of congestive heart failure in the community","volume":"12","author":"Hagstr\u00f6m","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"40","key":"10.1016\/j.ccl.2021.05.001_bib91","doi-asserted-by":"crossref","first-page":"e4810","DOI":"10.1097\/MD.0000000000004810","article-title":"Parathyroid hormone and risk of heart failure in the general population: a meta-analysis of prospective studies","volume":"95","author":"Meng","year":"2016","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.ccl.2021.05.001_bib92","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/CIRCHEARTFAILURE.114.001272","article-title":"Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease","volume":"7","author":"Wannamethee","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10.1016\/j.ccl.2021.05.001_bib93","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.ccl.2021.05.001_bib94","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2362.2011.02631.x","article-title":"Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure","volume":"42","author":"Plischke","year":"2012","journal-title":"Eur J Clin Invest"},{"issue":"10","key":"10.1016\/j.ccl.2021.05.001_bib95","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ccl.2021.05.001_bib96","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccl.2021.05.001_bib97","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s40265-018-0905-7","article-title":"Burosumab: first global approval","volume":"78","author":"Lamb","year":"2018","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.ccl.2021.05.001_bib98","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbmr.4233","article-title":"Burosumab for the treatment of tumor-induced osteomalacia","volume":"36","author":"Jan de Beur","year":"2021","journal-title":"J\u00a0Bone Miner Res"},{"issue":"8","key":"10.1016\/j.ccl.2021.05.001_bib99","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/eurheartj\/ehl542","article-title":"Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry","volume":"28","author":"Gheorghiade","year":"2007","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.ccl.2021.05.001_bib100","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/01.CIR.0000165065.82609.3D","volume":"111","author":"Klein","year":"2005","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ccl.2021.05.001_bib101","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/qjmed\/hcn061","article-title":"Mild hyponatremia and risk of fracture in the ambulatory elderly","volume":"101","author":"Gankam Kengne","year":"2008","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.ccl.2021.05.001_bib102","doi-asserted-by":"crossref","first-page":"71.e1","DOI":"10.1016\/j.amjmed.2005.09.026","article-title":"Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits","volume":"119","author":"Renneboog","year":"2006","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.ccl.2021.05.001_bib103","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM198402093100603","article-title":"Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia","volume":"310","author":"Dzau","year":"1984","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ccl.2021.05.001_bib104","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2215\/CJN.03700410","article-title":"Damned if you do, damned if you don't: potassium binding resins in hyperkalemia","volume":"5","author":"Watson","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ccl.2021.05.001_bib105","first-page":"267","article-title":"Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis","volume":"101","author":"Lillemoe","year":"1987","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.ccl.2021.05.001_bib106","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/SMJ.0b013e31819e8978","article-title":"Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol","volume":"102","author":"McGowan","year":"2009","journal-title":"South Med J"},{"issue":"3","key":"10.1016\/j.ccl.2021.05.001_bib107","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccl.2021.05.001_bib108","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia","volume":"372","author":"Packham","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccl.2021.05.001_bib109","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000071292","article-title":"Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth","volume":"67","author":"Strid","year":"2003","journal-title":"Digestion"},{"issue":"2","key":"10.1016\/j.ccl.2021.05.001_bib110","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ki.2012.345","article-title":"Chronic kidney disease alters intestinal microbial flora","volume":"83","author":"Vaziri","year":"2013","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.ccl.2021.05.001_bib111","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2215\/CJN.03600807","article-title":"Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients","volume":"3","author":"Szeto","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.ccl.2021.05.001_bib112","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","article-title":"Gut microbiota in cardiovascular health and disease","volume":"120","author":"Tang","year":"2017","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.ccl.2021.05.001_bib113","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1681\/ASN.2013080905","article-title":"The gut microbiome, kidney disease, and targeted interventions","volume":"25","author":"Ramezani","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.ccl.2021.05.001_bib114","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.ccl.2021.05.001_bib115","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","article-title":"Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ccl.2021.05.001_bib116","first-page":"432","article-title":"Sevelamer hydrochloride use and circulating endotoxin in hemodialysis patients: a pilot cross-sectional study","volume":"19","author":"Sun","year":"2009","journal-title":"J\u00a0Ren Nutr"},{"issue":"4","key":"10.1016\/j.ccl.2021.05.001_bib117","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1086\/367990","article-title":"Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia","volume":"187","author":"Lynn","year":"2003","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ccl.2021.05.001_bib118","doi-asserted-by":"crossref","first-page":"376128","DOI":"10.1155\/2012\/376128","article-title":"Effect of an oral adsorbent, AST-120, on dialysis initiation and survival in patients with chronic kidney disease","volume":"2012","author":"Hatakeyama","year":"2012","journal-title":"Int J Nephrol"},{"issue":"17","key":"10.1016\/j.ccl.2021.05.001_bib119","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1161\/CIR.0000000000000920","article-title":"Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart Association","volume":"142","author":"Rangaswami","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccl.2021.05.001_bib120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865121000394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865121000394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:55:12Z","timestamp":1760007312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865121000394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":120,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0733865121000394"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2021.05.001","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiorenal Syndrome","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2021.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}